BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36934378)

  • 21. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
    Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
    Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of regional lymph nodes in the elderly melanoma patient: patient selection, accuracy and prognostic implications.
    Grotz TE; Puig CA; Perkins S; Ballman K; Hieken TJ
    Eur J Surg Oncol; 2015 Jan; 41(1):157-64. PubMed ID: 25468751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma nodal management in Ontario the year after the 2012 American Society of Clinical Oncology and Society of Surgical Oncology guideline.
    Latosinsky S; Allen B; Shariff SZ
    Curr Oncol; 2019 Oct; 26(5):330-337. PubMed ID: 31708651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does very early timing of lymph node surgery after resection of the primary tumour improve the clinical outcome of patients with melanoma?
    Gambichler T; Bünnemann H; Scheel CH; Bechara FG; Stücker M; Stockfleth E; Becker JC
    Clin Exp Dermatol; 2020 Dec; 45(8):1011-1018. PubMed ID: 32422686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost.
    Hu Y; Briggs A; Gennarelli RL; Bartlett EK; Ariyan CE; Coit DG; Brady MS
    Ann Surg Oncol; 2020 Dec; 27(13):5248-5256. PubMed ID: 32514805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research progress of sentinel lymph node biopsy and regional dissection in melanoma].
    Liu WF; Yang FJ; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):481-485. PubMed ID: 31357833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Completion lymph node dissection for merkel cell carcinoma.
    Cramer JD; Suresh K; Sridharan S
    Am J Surg; 2020 Oct; 220(4):982-986. PubMed ID: 32087988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
    Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
    Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma.
    van Akkooi ACJ; Schadendorf D; Eggermont AMM
    Eur J Cancer; 2023 Mar; 182():163-169. PubMed ID: 36681612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?
    Perez MC; Oliver DE; Weitman ES; Boulware D; Messina JL; Torres-Roca J; Cruse CW; Gonzalez RJ; Sarnaik AA; Sondak VK; Wuthrick EJ; Harrison LB; Zager JS
    Ann Surg Oncol; 2019 Feb; 26(2):379-385. PubMed ID: 30311164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
    Eroglu Z; Broman KK; Thompson JF; Nijhuis A; Hieken TJ; Kottschade L; Farma JM; Hotz M; Deneve J; Fleming M; Bartlett EK; Sharma A; Dossett L; Hughes T; Gyorki DE; Downs J; Karakousis G; Song Y; Lee A; Berman RS; van Akkooi A; Stahlie E; Han D; Vetto J; Beasley G; Farrow NE; Hui JYC; Moncrieff M; Nobes J; Baecher K; Perez M; Lowe M; Ollila DW; Collichio FA; Bagge RO; Mattsson J; Kroon HM; Chai H; Teras J; Sun J; Carr MJ; Tandon A; Babacan NA; Kim Y; Naqvi M; Zager J; Khushalani NI
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial.
    Egger ME; Kimbrough CW; Stromberg AJ; Quillo AR; Martin RC; Scoggins CR; McMasters KM
    Ann Surg Oncol; 2016 Mar; 23(3):1019-25. PubMed ID: 26744107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
    Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
    Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.
    Chu BS; Koffi W; Hoehn RS; Ertel A; Shah SA; Ahmad SA; Sussman JJ; Neuman HB; Abbott DE
    J Surg Oncol; 2017 Dec; 116(8):1176-1184. PubMed ID: 28743173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher rates of regional disease but improved outcomes in pediatric versus adult melanoma.
    Lautz TB; Fahy AS; Helenowski I; Wayne JD; Baertschiger RM; Aldrink JH
    J Pediatr Surg; 2022 Oct; 57(10):425-429. PubMed ID: 34872730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.
    Torphy RJ; Friedman C; Ho F; Leonard LD; Thieu D; Lewis KD; Medina TM; Robinson WA; Gonzalez RC; Stewart CL; Kounalakis N; McCarter MD; Gleisner A
    Ann Surg Oncol; 2022 Feb; 29(2):806-815. PubMed ID: 34537899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.